Tesamorelin has two Phase III lipodystrophy trials (LIPO-010 and CTR-1011), pooled analyses across 816 participants, the Stanley 2019 Lancet HIV NAFLD trial, the Stanley 2014 JAMA abdominal-fat trial, and mechanistic transcriptomic and proteomic follow-up papers
Exercise, Diet & Periods
January 7, 2026: Patients Taking Mounjaro For Weight Loss May Regain Weight Faster After They Stop the Drug A survey study published in the British Medical Journal suggests that taking a weight management medication may be associated with a higher risk of rapid weight regain after patients stop taking the medication
Fuel your fitness goals with Exalt The Carni Burn, featuring 4200mg of L-Carnitine and 10mg Yohimbine per serving
However, without robust appetite modulation, the long-term effect on body composition may be limited
We stated that we welcome further evidence that compares the Axoguard HA+ Nerve Protector TM to currently available treatments in the clinical setting where it is most likely to be used
